Human interferon status. Standardization of the tests and establishing reference values

Background. Interferons are the most important component of nonspecific (congenital) resistance of the body, the history of their discovery dates back to 1957 and the study is still ongoing. Evaluation of an individual interferon status (IS) with the estimation of the sensitivity of leukocytes to immune reactive drugs has a practical aspect. IS is a set of parameters indicating the state of nonspecific resistance.
Aim. To study the problems of standardizing the IS tests with the search for possible ways of standardizing the method and calculate reference values based on a large amount of data.
Materials and methods. A retrospective statistical processing was performed using the database of the IS tests performed in the clinical diagnostic department of the laboratory center of Exacte Labs LLC from September 2020 to August 2022. Enzyme immunoassay kits based on commercial reagents were used. The paper describes the methodology for studying IS with an emphasis on the least standardized procedures.
Results. Reference values were calculated using three indirect methods. The analysis of the results obtained made it possible to identify age groups for which it is advisable to establish reference values. The study results showed the inconsistency of the obtained reference values as compared with the previous ones, which indicates the need for their correction.
Conclusion. The considered problems of performing and standardizing the method for IS analysis are of practical importance for establishing a standard methodology and an in vitro method. The reference values have been updated to avoid errors in the interpretation of the results and to increase the clinical significance of the study.

1. Kopitar-Jerala N. The role of interferons in inflammation and inflammasome activation. Front Immunol 2017;8:873. DOI: 10.3389/fimmu.2017.00873

2. Ershov F.I., Novokhvatskiy A.S. Interferon and its inducers. Moscow: Meditsina, 1980. 173 p. (In Russ.).

3. Solovyov V.D., Bektemirov T.A. Interferon in the theory and practice of medicine. Moscow: Meditsina, 1981. 400 p. (In Russ.).

4. Ershov F.I., Kiselev O.I. Interferons and their inducers (from molecules to drugs). Moscow: GEOTAR-Media, 2005. 368 p. (In Russ.).

5. Pleyfeyer G., Cheyne B.M. Transparent immunology. 20th edn. revised and enlarged. Moscow: GEOTAR-Media, 2008. 120 p. (In Russ.).

6. Doldi K., Leroux M., Augustin R. et al. Proliferation and interferon production in whole blood samples and isolated lymphocyte preparations. J Interferon Res 1985;5(1):55–64. DOI: 10.1089/jir.1985.5.55

7. Grigoryan S.S., Аrutyunyan R.А. The method for determining the sensitivity of the individual human blood leukocytes to the drug. Patent RU No. 2324705 dated 15.06.2009. (In Russ.).

8. Grigoryan S.S., Maiorov I.A., Ivanova A.M. et al. Evaluation of the interferon status of people on samples of whole blood. Voprosy virusologii = Questions of Virology 1988;3(4):433–6. (In Russ.).

9. Ершов Ф.И., Готовцева Е.П., Носик Н.Н. Интерфероновый статус в норме. Иммунология 1986;3:52–4. Ershov F.I., Gotovtseva E.P., Nosik N.N. Interferon status is normal. Immunology 1986;3:52–4.

10. Ospelnikova T.P., Kolodyazhnaya L.V., Tabakov V.Yu. Determination of interferon status as an indicator of nonspecific resistance of the human body. Practical recommendations. Moscow, 2018. 26 p. (In Russ.).

11. Evgina S.A., Saveliev L.I. Modern theory and practice of reference intervals. Laboratornaya sluzhba = Laboratory service 2019;8(2):36–44. (In Russ.). DOI: 10.17116/labs2019802136

12. CLSI Document C28-A3c. Defining, establishing, and verifying reference intervals in the clinical laboratory. Approved guideline – third edition. Wayne, Pa., USA: CLSI, 2010.

13. Jones G., Haeckel R., Loh T. et al. Indirect methods for reference interval determination – review and recommendations. Clin Chem Lab Med 2019;57(1):20–9. DOI: 10.1515/cclm-2018-0073

14. Hoffmann R.G. Statistics in the practice of medicine. JAMA 1963;185:864–73. DOI: 10.1001/jama.1963.03060110068020

15. Arzideh F., Wosniok W., Gurr E. et al. A plea for intra-laboratory reference limits. Part 2. A bimodal retrospective concept for determining reference limits from intra-laboratory databases demonstrated by catalytic activity concentrations of enzymes. Clin Chem Lab Med 2007;45(8):1043–57. DOI: 10.1515/CCLM.2007.250

16. Concordet D., Geffré A., Braun J.P. et al. A new approach for the determination of reference intervals from hospital-based data. Clin Chim Acta 2009;405(1–2):43–8. DOI: 10.1016/j.cca.2009.03.057

17. Mining your routine data for reference intervals: Hoffmann, Bhattacharya and maximum likelihood. The Lab-R-torian. Available at: https://labrtorian.com/2017/09/05/mining-your-routine-data-for-reference-intervals-hoffman-bhattacharya-and-maximum-likelihood (accessed 05.10.2022).